The University of Chicago Header Logo

Connection

Koen Van Besien to Deoxycytidine

Back to Details
This is a "connection" page, showing publications Koen Van Besien has written about Deoxycytidine.
Koen Van Besien
Connection Strength
0.041
Deoxycytidine
  1. A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas. Br J Haematol. 2013 Oct; 163(1):55-61.
    View in: PubMed
    Score: 0.025
  2. Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol. 2007 Jun; 18(6):1071-9.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.